Nucleus Network Revenue and Competitors

Melbourne, AU

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Nucleus Network's estimated annual revenue is currently $72M per year.(i)
  • Nucleus Network's estimated revenue per employee is $127,500

Employee Data

  • Nucleus Network has 565 Employees.(i)
  • Nucleus Network grew their employee count by 7% last year.

Nucleus Network's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Marketing and CustomerReveal Email/Phone
3
Recruitment OfficerReveal Email/Phone
4
Recruitment OfficerReveal Email/Phone
5
Clinical Trials OfficerReveal Email/Phone
6
Laboratory Support OfficerReveal Email/Phone
7
Medical Officer and Sub-InvestigatorReveal Email/Phone
8
Participant Success OfficerReveal Email/Phone
9
Clinical Trial OfficerReveal Email/Phone
10
Technical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.3M911%N/AN/A
Add Company

What Is Nucleus Network?

Nucleus Network is Australia’s leading clinical research organisation for the conduct of Early Phase Clinical Trials– its people, facilities and problem-solving culture provide excellent service to global pharmaceutical and biotechnology companies. The organisation is an instrumental part of the process which brings new medicines to the community. Early Phase Clinical Research

keywords:N/A

N/A

Total Funding

565

Number of Employees

$72M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nucleus Network News

2022-04-17 - The first subjects dosed successfully with no adverse events in the phase I trial of BSG005

The phase I study is conducted in the Nucleus Network phase I Unit in Melbourne, Australia . It has three defined objectives:.

2022-04-17 - The first subjects dosed successfully with no adverse events in the phase I trial of BSG005

The phase I study is conducted in the Nucleus Network phase I Unit in Melbourne, Australia . It has three defined objectives:.

2022-04-13 - A Guide to Preclinical and CMC Requirements for Conducting ...

Jason Lickliter, Chief Medical Officer, Nucleus Network; and Dr. Jon Fairweather, Business Development Executive, PCI Pharma Services for...

2022-04-13 - A Guide to Preclinical and CMC Requirements for Conducting ...

Jason Lickliter, Chief Medical Officer, Nucleus Network; and Dr. Jon Fairweather, Business Development Executive, PCI Pharma Services for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$191.7M5688%N/A
#2
$35M57127%N/A
#3
$163.9M5753%N/A
#4
$75M5805%N/A
#5
$15M582N/AN/A